Abstract
Cooling and induction of electromechanical arrest (cardioplegia) limit myocardial damage during open-heart operations. Many studies provide evidence for the use of calcium entry blockers, as adjuncts to cardioplegia to optimize the protection. This paper reviews their possible mechanism of action, application time, and efficacy during hypothermia. A major conclusion is that negative effects are virtually absent, apart from short-term negative inotropic responses. There is an increasing body of positive evidence for their efficacy. A new development is the use of these drugs for regional cardioplegia during dilation of coronary arteries (coronary angioplasty).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen BS, Okamoto F, Buckberg GD, Acar C, Partington M, Bugyi H, Leaf J: Studies of controlled reperfusion after ischemia. IX. Reperfusate composition: Benefits of marked hypocalcemia and diltiazem on regional recovery. J Thorac Cardiovasc Surg 92:564–572, 1986
Altura BM, Altura BT, Carella A, Gebrewold A, Murakawa T, Nishio A: Mg2+ - Ca2+ interaction in contractility of vascular smooth muscle: Mg2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels. Can J Physiol Pharmacol 65:729–745, 1987
Baker JE, Hearse DJ: The temperature-sensitivity of slow calcium channel blockers in relation to their effect upon the calcium paradox. Eur Heart J 4, Suppl H:97–103, 1983
Baraka A, Usta N, Baroody M, Haroun S, Dagher I, Haddad R: Verapamil pretreatment before aortic cross-clamping in patients undergoing coronary artery bypass graft. Anesth Analg 66:560–564, 1987
Barner HB, Swartz MT, Devine JE, Williams GA, Janosik D: Diltiazem as an adjunct to cold blood potassium cardioplegia: A clinical assessment of dose and prospective randomization. Ann Thorac Surg 43:191–197, 1987
Bernard M, Menasché P, Fontanarava E, Canioni P, Grousset C, Piwnica A, Cozzone P: Effect of nifedipine in hypothermic cardioplegia: a phosphorus-31 nuclear magnetic resonance study. Clin Chim Acta 152: 43–53, 1985
Boe SL, Dixon CM, Sakert TA, Magovern G J: The control of myocardial Ca+ + sequestration with nifedipine cardioplegia. J Thorac Cardiovasc Surg 84:678–683, 1982
Buckberg GD: A proposed “solution” to the cardioplegic controversy. J Thorac Cardiovasc Surg 77:803–815, 1979
Buckberg GD, Olinger GN, Mulder DG, Maloney Jr JV: Depressed postoperative cardiac performance. Prevention by adequate myocardial protection during cardiopulmonary bypass. J Thorac Cardiovasc Surg 70:974–988, 1975
Buhrman C, Molter DW, German LD, Lowe E: Heart block associated with high magnesium cardioplegia. J Am Coll Cardiol 9:7a, 1987 (Abstr)
Bush LR, Li Y-P, Shlafer M, Jolly SR, Lucchesi BR: Protective effects of diltiazem during myocardial ischemia in isolated cat hearts. J Pharmacol Exp Ther 218:653–661, 1981
Casson WR, Jones RM, Parsons RS: Nifedipine and cardiopulmonary bypass. Post-bypass management after continuation or withdrawal of therapy. Anaesthesia 36:1197–1201, 1984
Cavero I, Boudot J-P, Feuvray D: Diltiazem protects the isolated rabbit heart from the mechanical and ultra-structural damage produced by transient hypoxia, low-flow ischemia, and exposure to Ca+ +-free medium. J Pharmacol Exp Ther 226:258–268, 1983
Chiavarelli M, Chiavarelli R, Macchiarelli A, Carpi A, Marino B: Calcium entry blockers and cardioplegia: Interaction between nifedipine, potassium, and hypothermia. Ann Thorac Surg 41:535–541, 1986
Christakis GT, Fremes SE, Weisel RD, Tittley JG, Mickle DAG, Ivanov J, Madonik MM, Benak AM, McLaughlin PR, Baird RJ: Diltiazem cardioplegia. A balance of risk and benefit. J Thorac Cardiovasc Surg 91:647–661, 1986
Christheb IY, Clark RE, Sobel BE. Three-hour preservation of the hypothermic globally ischemic heart with nifedipine. Surgery 90:947–955, 1981
Clark RE: Verapamil, cardioplegia and coronary artery bypass grafting. Ann Thorac Surg 41:585–586, 1986
Clark RE, Christheb IY, Spratt JA, Henry PD, Fischer AE, Williamson JR, Sobel BR: Myocardial preservation with nifedipine: A comparative study at normothermia. Ann Thorac Surg 31:3–19, 1981
Clark RE, Magovern GJ, Christheb IY, Boe S: Nifedipine cardioplegia experience: Results of a 3-year cooperative clinical study. Ann Thorac Surg 36:654–663, 1983
De Jong JW: Timely administration of nisoldipine essential for prevention of myocardial ATP catabolism. Eur J Pharmacol 118:53–59, 1985
De Jong JW: Cardioplegia and calcium antagonists: A review. Ann Thorac Surg 42:593–598, 1986
De Jong JW, Harmsen E, De Tombe PP: Diltiazem administered before or during myocardial ischemia decreases adenine nucleotide catabolism. J Mol Cell Cardiol 16:363–370, 1984
De Jong JW, Harmsen E, De Tombe PP, Keijzer E: Nifedipine reduces adenine nucleotide breakdown in ischemic rat heart. Eur J Pharmacol 81:89–96, 1982
De Jong JW, Huizer T, Tijssen JGP: Energy conservation by nisoldipine in ischaemic heart. Br J Pharmacol 118:943–949, 1984
Ferguson Jr TB, Damiano RJ, Smith PK, Buhrman WC, Cox JL: The electrophysiological effects of calcium channel blockade during standard hyperkalemic hypothermic cardioplegic arrest. Ann Thorac Surg 41:622–629, 1986
Flameng W, Borgers M, Van der Vusse GJ, De Meyere R, Van der Meersch F, Thoné F, Suy R: Cardioprotective effects of lidoflazine in extensive aorta-coronary bypass grafting. J Thorac Cardiovasc Surg 83:758–768, 1983
Flameng W, De Meyere R, Daenen W, Sergeant P, Ngalikpima V, Geboers J, Suy R, Stalpaert G: Nifedipine as an adjunct to St. Thomas’ Hospital cardioplegia. A double-blind placebo controlled, randomized clinical trial. J Thorac Cardiovasc Surg 91:723–731, 1986
Fleckenstein A: Calcium antagonism in heart and smooth muscle. Experimental facts and therapeutic prospects. New York: Wiley, 1983:36–40
Fox KAA, Bergmann SR, Sobel BE: Pathophysiology of myocardial reperfusion. Annu Rev Med 36:125–144, 1985
Fukunami M, Hearse DJ: Temperature-dependency of nifedipine as a protective agent during cardioplegia in the rat. Cardiovasc Res 19:95–103, 1985
Godfraind T: Classification of calcium antagonists. Am J Cardiol 55:11B–23B, 1987
Guffin AV, Kates RA, Holbrook GW, Jones EL, Kaplan JA: Verapamil and myocardial preservation in patients undergoing coronary artery bypass surgery. Ann Thorac Surg 41:587–591, 1986
Guyton RA, Dorsey LM, Colgan TK, Hatcher Jr CR: Calcium-channel blockade as an adjunct to heterogeneous delivery of cardioplegia. Ann Thorac Surg 35:626–632, 1983
Hearse DJ: The protection of the ischemic myocardium during open heart surgery: Cold chemical cardioplegia. Eur Heart J 4, Suppl C:77, 1983 (Abstr)
Hearse DJ: Discussion of Symp. on Calcium Antagonists and Cardioplegia in Cardiac Surgery. Eur Heart J 4, Suppl C:83–86, 1983
Hearse DJ, Erol C, Robinson LA, Maxwell MP, Braimbridge MV: Particle-induced coronary vasoconstriction during cardioplegic infusion — Characterization and possible mechanisms. J Thorac Cardiovasc Surg 89:428–438, 1985
Hearse DJ, Yamamoto F, Shatlock MJ: Calcium antagonists and hypothermia: The temperature dependency of the negative inotropic and anti-ischemic properties of verapamil in the isolated rat heart. Circulation 70, Suppl 1:154–164, 1984
Henry PD: Summary of Symp. on Calcium Antagonists and Cardioplegia in Cardiac Surgery. Eur Heart J 4, Suppl C:90–91, 1983
Hicks Jr GL, DeWeese JA: Verapamil potassium cardioplegia and cardiac conduction. Ann Thorac Surg 39:324–328, 1985
Hicks Jr GL, Salley RK, DeWeese JA: Calcium channel blockers: An intraoperative and postoperative trial in women. Ann Thorac Surg 37:319–323, 1984
Huizer T, De Jong JW, Achterberg PW: Protection by bepridil against myocardial ATP-catabolism is probably due to negative inotropy. J Cardiovasc Pharmacol, 10:55–61, 1987
Jennings RB, Steenbergen Jr C: Nucleotide metabolism and cellular damage in myocardial ischemia. Annu Rev Physiol 47:727–749, 1985
Johnson RG, Jacocks MA, Aretz TH, Geffin GA, O’Keefe DD, DeBoer LWV, Guyton RA, Fallon JT, Daggett WM: Comparison of myocardial preservation with hypothermic potassium and nifedipine arrest. Circulation 66, Suppl I:173–180, 1982
Kaplan JA, Guffin AV, Jones EL, Kates R, Holbrook GW: Verapamil and myocardial preservation in patients undergoing coronary artery bypass surgery. In: Althaus U, Burckhardt D, Vogt E, eds: Proc Calcium-Antagonismus/Int Symp on Calcium Antagonism, Frankfurt/Main: Universimed, 1984:228–237
Kates RA, Dorsey LM, Kaplan JA, Hatcher Jr CR, Guyton RA: Pretreatment with lidoflazine, a calcium-channel blocker. Useful adjunct to heterogeneous cold potassium cardioplegia. J Thorac Cardiovasc Surg 85:278–286, 1983
Katsumoto K, Inoue T: Experimental comparison of the efficacy of various agents on the enhancement of myocardial protection. Jpn Circ J 47:356–362, 1983
Kober G, Kästner R, Hopf R, Kaltenbach M: Die direkte myokardiale antiischämische Wirkung von Diltiazem beim Menschen. Z Kardiol 75:386–393, 1986
Krukenkamp IB, Silverman NA, Sorlie D, Pridjian A, Levitsky S: Temperature-specific effects of adjuvant diltiazem therapy on myocardial energetics following potassium cardioplegic arrest. Ann Thorac Surg 42:675–680, 1986
Laird-Meeter K, Van den Brand MJBM, Serruys PW, Penn OCKM, Haalebos MMP, Bos E, Hugenholtz PG: Reoperation after aortocoronary bypass procedure. Results in 53 patients in a group of 1041 with consecutive first operations. Br Heart J 50:157–162, 1983
Landymore RW, Marble AE, Trillo A, Faulkner G, MacAulay MA, Cameron C: Prevention of myocardial electrical activity during ischemic arrest with verapamil cardioplegia. Ann Thorac Surg 43:534–538, 1987
Lupinetti FM, Hammon Jr JW, Huddleston CB, Boucek Jr RJ, Bender Jr HW: Global ischemia in the immature canine ventricle. Enhanced protective effect of verapamil and potassium. J Thorac Cardiovasc Surg 87:213–219, 1984
Magovern GJ, Dixon CM, Burkholder JA: Improved myocardial protection with nifedipine and potassium-based cardioplegia. J Thorac Cardiovasc Surg 82:239–244, 1981
McAllister Jr RG, Hamann SR, Blouin RA: Pharmacokinetics of calcium-entry blockers. Am J Cardiol 55:30B-40B, 1985
Menasché P, Groussett C, Piwnica A: Bases ioniques des solutions cardioplégiques. II. Influence de la formule ionique d’une solution cardioplégique sur la préservation métabolique et fonctionelle du myocarde ischémique. Evalution expérimentale par résonance magnétique nucléaire du phosphore 31 et applications à la chirurgie cardiaque. Arch Mal Coeur 76:1465–1474, 1983
Moores WY, Mack JW, Dembitsky WP, Heydorn WH, Daily PO: Quantitative evaluation of the myocardial preservative characteristics of nifedipine during hypothermic myocardial ischemia. J Thorac Cardiovasc Surg 90:912–920, 1985
Morishita Y, Saigenji H, Umebayashi Y, Higashi T, Taira A, Goto M: Potassium-verapamil cardioplegia for myocardial protection: An experimental evaluation through preservation and transplantation. Jpn J Surg 13:524–529, 1983
Nayler WG: Cardioprotective effects of calcium ion antagonists in myocardial ischemia. Clin Invest Med 3:91–99, 1980
Nayler WG: Protection of the myocardium against postischemic reperfusion damage. The combined effect of hypothermia and nifedipine. J Thorac Cardiovasc Surg 84:897–905, 1982
Nayler WG, Panagiotopoulos S, Elz JS, Sturrock WJ: Fundamental mechanisms of action of calcium antagonists in myocardial ischemia. Am J Cardiol 59:75B–83B, 1987
Pang DC, Sperelakis N: Nifedipine, diltiazem, bepridil and verapamil uptakes into cardiac and smooth muscles. Eur J Pharmacol 87:199–207, 1983
Pinsky WW, Lewis RM, McMillin-Wood JB, Hara H, Hartley CJ, Gillette PC, Entman ML: Myocardial protection from ischemic arrest: Potassium and verapamil cardioplegia. Am J Physiol 240:H326–H335, 1981
Piper HM, Huetter JF, Spieckermann PG: Temperature dependence of calcium antagonist action. Arzneimittelforsch 35:1495–1498, 1985
Pop G, Serruys PW, Piscione F, De Feyter PJ, Van den Brand M, Huizer T, De Jong JW, Hugenholtz PG: Regional cardioprotection by subselective intracoronary nifedipine is not due to enhanced collateral flow during coronary angioplasty. Int J Cardiol 15:27–41, 1987
Preusse CJ, Gebhard MM, Schnabel A, Ulbricht LT, Bretschneider HJ: Post-ischemic myocardial function after pre-ischemic application of propranolol or verapamil. J Cardiovasc Surg 25:158–164, 1984
Ruigrok TJC, Boink ABTJ, Slade A, Zimmerman ANE, Meijler FL, Nayler WG: The effect of verapamil on the calcium paradox. Am J Pathol 98:769–782, 1980
Serruys PW, Brower RW, Ten Katen HJ, Meester GT: Recovery from circulatory depression after coronary artery bypass surgery. Eur Surg Res 12:369–382, 1980
Serruys PW, Van den Brand M, Brower RW, Hugenholtz PG: Regional cardioplegia and cardioprotection during transluminal angioplasty, which role for nifedipine? Eur Heart J 4, Suppl C:115–121, 1983
Shahian DM: Concepts and techniques of myocardial protection for adult open heart surgery. Surg Clin North Am 65:323–346, 1985
Spencer FC: Intellectual creativity in thoracic surgeons. J Thorac Cardiovasc Surg 86:163–179, 1983
Standeven JW, Jellinek M, Menz U, Kolata RJ, Barner HB: Cold blood potassium diltiazem cardioplegia. J Thorac Cardiovasc Surg 87:201–212, 1984
Van Gilst WH, Boonstra PW, Terpstra JA, Wildevuur CRH, De Langen CDJ: Improved recovery of cardiac function after 24 h of hypothermic arrest in the isolated rat heart: Comparison of a prostacyclin analogue (ZK 36 374) and a calcium entry blocker (diltiazem). J Cardiovasc Pharmacol 7:520–524, 1985
Vouhé PR, Loisance DY, Aubry P, Piszker G, Cazor JL, Cachera J-P: Double-blind evaluation of the intraoperative use of diltiazem during coronary artery surgery. In: Just H, Schroeder JS, eds: Advances in Clinical Applications of Calcium Antagonist Drugs. Int Diltiazem Workshop. Düsseldorf: Excerpta Med, 1985:91–104
Wallis DE, Gierke LW, Scanlon PJ, Wolfson PM, Kopp SJ: Sustained postischemic cardiodepression following magnesium-diltiazem cardioplegia. Proc Soc Exp Biol Med 182:375–385, 1986
Watts JA, Maiorano LJ, Maiorano PC: Comparison of the protective effects of verapamil, diltiazem, nifedipine, and buffer containing low calcium upon global myocardial ischemic injury. J Mol Cell Cardiol 18:255–263, 1986
White BC, Winegar CD, Wilson RF, Krause GS: Calcium blockers in cerebral resuscitation. J Trauma 23:788–793, 1983
Yamamoto F, Manning AS, Braimbridge MV, Hearse DJ: Calcium antagonists and myocardial protection: Diltiazem during cardioplegic arrest. Thorac Cardiovasc Surg 31:369–373, 1983
Yamamoto F, Manning AS, Braimbridge MV, Hearse DJ: Nifedipine and cardioplegia: Rat heart studies with the St. Thomas’ cardioplegic solution. Cardiovasc Res 17:719–727, 1983
Yamamoto F, Manning AS, Crome R, Braimbridge MV, Hearse DJ: Calcium antagonists and myocardial protection: A comparative study of the functional, metabolic and electrical consequences of verapamil and nifedipine as additives to the St. Thomas’ cardioplegic solution. Thorac Cardiovasc Surg 33:354–359, 1985
Yoon SB, McMillin-Wood JB, Michael LH, Lewis RM, Entman ML: Protection of canine cardiac mitochondrial function by verapamil-cardioplegia during ischemic arrest. Circ Res 56:704–708, 1985
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
de Jong, J.W. (1988). Cardioplegia and Calcium Entry Blockade. In: De Jong, J.W. (eds) Myocardial Energy Metabolism. Developments in Cardiovascular Medicine, vol 91. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1319-6_24
Download citation
DOI: https://doi.org/10.1007/978-94-009-1319-6_24
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7087-4
Online ISBN: 978-94-009-1319-6
eBook Packages: Springer Book Archive